Research

Clinical Trials

Current Open Studies

At Sansum Diabetes Research Institute, we are committed to advancing science and improving lives through innovative clinical research. Our current studies are designed to explore new treatments, technologies, and approaches to diabetes care—with a focus on real-world impact.

Explore our actively enrolling studies below and see how you or a loved one may be eligible to participate. Clinical trial participants play a vital role in the discovery of tomorrow’s breakthroughs.

Connect with our Research Staff

INHALE GDM - Gestational Diabetes

  • Trial Design: Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women with Gestational Diabetes
  • Inclusion Criteria:
    • Age ≥18 years and <50 years old
    • Singleton pregnancy at 24-34 weeks gestation
    • Treated with an insulin regimen
  • NCT Number: NCT06535789
  • Learn More Here
  • Principal Investigator: Kristin Castorino
  • Status: Recruiting
Join This Study - Contact Us

Evaluation of Continuous Glucose Monitoring Systems in Pediatrics with Diabetes

  • Trial Design: Participants will wear up to 3 study CGM systems for up to 16 days
  • Inclusion Criteria:
    • Ages between 2-17
    • Clinical diagnosis of type 1 or type 2 diabetes
  • Principal Investigator: Kristin Castorino
  • Status: Recruiting
Join This Study - Contact Us

Evaluation of the Performance of an Interstitial Fluid Glucose Sensor

  • Trial Design: Participants will wear 2 study CGM systems for 30 days with up to four 10-hour clinic visits
  • Inclusion Criteria:
    • At least one year of age
    • Must have type 1 or type 2 diabetes
    • Must require insulin therapy
  • NCT Number: NCT07215793
  • Learn More Here
  • Principal Investigator: Kristin Castorino
  • Status: Recruiting
Join This Study - Contact Us